Acquisitions (Tables)

12 Months Ended

Sep. 30, 2014

Cato [Member]

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.


(Millions of dollars)
Developed technology	$	9
Other intangibles		4
Other assets		1

Total identifiable assets acquired		14

Liabilities assumed		(2	)

Net identifiable assets acquired		12
Goodwill		11

Net assets acquired	$	23

Safety Syringes [Member]

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.


(Millions of dollars)
Developed technology	$	69
Other intangibles		5
Property, plant and equipment, net		7
Trade receivables, net		7
Other		7

Total identifiable assets acquired		93

Liabilities assumed		(4	)

Net identifiable assets acquired		90
Goodwill		34

Net assets acquired	$	124

Sirigen Group Limited [Member]

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.


(Millions of dollars)
Patent	$	11
Developed technology		19
Acquired in-process research and development		12
Deferred tax assets		3
Other		1

Total identifiable assets acquired		45

Deferred tax liabilities		(14	)
Other		(1	)

Total liabilities assumed		(15	)

Net identifiable assets acquired		30
Goodwill		34

Net assets acquired	$	64

KIESTRA Lab Automation BV [Member]

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the acquisition date.


(Millions of dollars)
Developed technology	$	13
Acquired in-process research and development		7
Other intangibles		5
Property, plant and equipment		5
Other		10

Total identifiable assets acquired		40

Deferred tax liabilities		(6	)
Other		(12	)

Total liabilities assumed		(18	)

Net identifiable assets acquired		22
Goodwill		35

Net assets acquired	$	58